AstraZeneca Sells its Cholesterol Drug to German Pharma
On December 1st, AstraZeneca announced it would sell the rights of Crestor (Rosuvastatin) in over 30 countries in Europe to the privately-owned German company, Grünenthal GmbH (Grünenthal) for an upfront …
Read More